0001477932-21-006913.txt : 20210930 0001477932-21-006913.hdr.sgml : 20210930 20210930104548 ACCESSION NUMBER: 0001477932-21-006913 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210930 DATE AS OF CHANGE: 20210930 EFFECTIVENESS DATE: 20210930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Incordex Corp. CENTRAL INDEX KEY: 0001818550 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 981541457 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-248609 FILM NUMBER: 211294082 BUSINESS ADDRESS: STREET 1: 6 ROSEMARY WAY CITY: NUNEATON STATE: X0 ZIP: CV10 7ST BUSINESS PHONE: 00442039911252 MAIL ADDRESS: STREET 1: 6 ROSEMARY WAY CITY: NUNEATON STATE: X0 ZIP: CV10 7ST NT 10-K 1 incordex_nt10k.htm NT 10-K incordex_nt10k.htm

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

(Check one):

☒      Form 10-K

☐      Form 20-F

☐      Form 11-K

☐      Form 10-Q

☐      Form 10-D

☐      Form N-SAR

☐      Form N-CSR

  

 

For Period Ended: June 30, 2021                    

 

 

 

 

Transition Report on Form 10-K

 

Transition Report on Form 20-F

 

Transition Report on Form 11-K

 

Transition Report on Form 10-Q

 

Transition Report on Form N-SAR

 

 

 

 

For the Transition Period Ended: ______________________________

  

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

Incordex Corp.

Full Name of Registrant

 

6 Rosemary Way

Address of Principal Executive Office (Street and Number)

 

Nuneaton, United Kingdom CV10 7ST

City, State and Zip Code

  

 

 

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

 

 

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

The registrant’s annual report on Form 10-K for the period ended June 30, 2021, could not be filed within the prescribed time period because the Company needs additional time to complete the financial statements and to prepare the Form 10-K. The registrant anticipates that it will require no more than the additional 15 days allowed to complete and file the Form 10-K.

 

PART IV — OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

Iurii Abramovici

 

+44-203

 

99-11-252

(Name)

 

(Area Code)

 

(Telephone Number)

 

(2)

 

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes      ☐ No

 

(3)

 

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes      ☒ No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

2

 

 

Incordex Corp.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 30, 2021

By:

/s/ Iurii Abramovici

 

 

 

Iurii Abramovici, President

 

 

 

3